The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

The Senate Parliamentarian reversed course on a small provision in the One Big Beautiful Bill Act that could boost cures for ...

Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for ...

Will the U.S. government adopt price controls on prescription drugs? If so, what would they look like? Seeking Alpha analysts ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

The Trump administration aims to issue a rule empowering regulators to “forcefully” go after companies that don’t share drug ...

President Donald Trump, ever the negotiator, is angling to lower drug prices through his Most Favored Nation policy. But will ...

The Orphan Cures Act has been added back into the Senate version of President Donald Trump’s “big, beautiful bill” after being ...

The policy introduces a most-favored-nation pricing model, expands Medicare’s ability to negotiate costs and pushes for more domestic drug manufacturing.

Americans pay disproportionately to subsidize pharmaceutical innovation, while the rest of the world benefits and pays less ...

The measure extending tax cuts and slashing the social safety net goes to President Trump for his signature, but the debate ...